LMR Partners’s Kindred Biosciences, Inc. KIN Stock Holding History

LMR Partners’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,977	Closed	-$183K	–	1324
2021 Q2	$183K	Buy	+19,977	New	+$116K	﹤0.01%	789
2015 Q3	–	Sell	-10,246	Closed	-$70K	–	538
2015 Q2	$70K	Buy	+10,246	New	+$72.7K	0.01%	468

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

LMR Partners's KIN Position: Q3 2021 in Review

LMR Partners sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 19,977 shares — an estimated $183K sold.

LMR Partners first reported a position in KIN in Q2 2015 and held it in 2 quarters. The position peaked at $183K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

LMR Partners reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
LMR Partners sold 19,977 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $183K.
LMR Partners first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 2 quarters.
LMR Partners's Kindred Biosciences, Inc. position peaked at $183K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on LMR Partners's 13F filing for Q3 2021, filed 15 Nov 2021.